Prior influenza vaccine is not a risk factor for bacterial coinfection in patients admitted to the ICU due to severe influenza.


Journal

Medicina intensiva
ISSN: 2173-5727
Titre abrégé: Med Intensiva (Engl Ed)
Pays: Spain
ID NLM: 101717568

Informations de publication

Date de publication:
08 2022
Historique:
received: 10 02 2021
accepted: 22 05 2021
entrez: 22 7 2022
pubmed: 23 7 2022
medline: 27 7 2022
Statut: ppublish

Résumé

To determine whether the prior usage of the flu vaccine is a risk factor for bacterial co-infection in patients with severe influenza. This was a retrospective observational cohort study of subjects admitted to the ICU. A propensity score matching, and logistic regression adjusted for potential confounders were carried out to evaluate the association between prior influenza vaccination and bacterial co-infection. 184 ICUs in Spain due to severe influenza. Patients included in the Spanish prospective flu registry. Flu vaccine prior to the hospital admission. A total of 4175 subjects were included in the study. 489 (11.7%) received the flu vaccine prior to develop influenza infection. Prior vaccinated patients were older 71 [61-78], and predominantly male 65.4%, with at least one comorbid condition 88.5%. Prior vaccination was not associated with bacterial co-infection in the logistic regression model (OR: 1.017; 95%CI 0.803-1.288; p=0.885). After matching, the average treatment effect of prior influenza vaccine on bacterial co-infection was not statistically significant when assessed by propensity score matching (p=0.87), nearest neighbor matching (p=0.59) and inverse probability weighting (p=0.99). No association was identified between prior influenza vaccine and bacterial coinfection in patients admitted to the ICU due to severe influenza. Post influenza vaccination studies are necessary to continue evaluating the possible benefits.

Identifiants

pubmed: 35868720
pii: S2173-5727(22)00153-9
doi: 10.1016/j.medine.2021.05.009
pii:
doi:

Substances chimiques

Influenza Vaccines 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

436-445

Informations de copyright

Copyright © 2021 Elsevier España, S.L.U. and SEMICYUC. All rights reserved.

Auteurs

N J Proaños (NJ)

Universidad de La Sabana, Chía, Colombia.

L F Reyes (LF)

Universidad de La Sabana, Chía, Colombia; Clínica Universidad de La Sabana, Chía, Colombia. Electronic address: luis.reyes5@unisabana.edu.co.

A Bastidas (A)

Universidad de La Sabana, Chía, Colombia.

I Martín-Loeches (I)

St James's University Hospital, Multidisciplinary Intensive Care Research Organization (MICRO), Trinity Centre for Health Sciences, Department of Anaesthesia and Critica Care, Dublin, Ireland.

E Díaz (E)

ICU Complejo Hospitalario Parc Taulí/UAB, Sabadell, Spain.

B Suberviola (B)

ICU Hospital Universitario Marqués de Valdecilla, Santander, Spain.

G Moreno (G)

ICU Hospital Universitario de Tarragona Joan XXIII, Tarragona, Spain.

M Bodí (M)

ICU Hospital Universitario de Tarragona Joan XXIII, Tarragona, Spain; IISPV/URV/CIBERES, Tarragona, Spain.

M Nieto (M)

ICU Hospital Clínico San Carlos, Madrid, Spain.

A Estella (A)

ICU Hospital de Jerez, Jerez de la Frontera, Spain.

J Sole-Violán (J)

ICU Hospital Universitario Dr. Negrín, Las Palmas de Gran Canaria, Spain.

D Curcio (D)

Departamento de Enfermedades Infecciosas, Universidad de Buenos Aires, Argentina.

E Papiol (E)

ICU Hospital Univseritario Vall d'Hebron, Barcelona, Spain.

J Guardiola (J)

University of Louisville and Robley Rex VA Medical Center, Division of Pulmonary, Critical Care and Sleep Medicine, Louisville, KY, United States.

A Rodríguez (A)

IISPV/URV/CIBERES, Tarragona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH